Vivia Biotech Signs Agreement to Implement UNIConnect’s UNIFlow Enterprise Laboratory Information Management System
News May 17, 2011
“Vivia is excited to work with UNIConnect to bring its critically important capabilities in personalized medicine to hospitals, physicians and patients,” said Juan Ballesteros, Vivia chairman and chief scientific officer. “The unique and flexible UNIFlow system has proven its reliability and efficiency and, after a rigorous review and selection process, we look forward to its full implementation.”
Vivia conducted a ten-week pilot project in order to validate the UNIFlow system’s ability to meet all current and future requirements. The pilot study confirmed that the UNIFlow data model is the strongest available technology to support Vivia’s complex and dynamic processes. Moreover, Vivia will be able to configure the software on their own, without a constant need to engage their software supplier. The UNIFlow system offers this advantage which keeps the software current after implementation.
“Our focus has always been to provide our partners with both strength and flexibility,” said William S. Harten, founder and chief executive officer of UNIConnect. “UNIFlow’s unique structure gives its laboratory users complete control both over customization and configuration, thus dramatically reducing the time required by other LIMS systems for development and deployment – giving our customers a clear competitive advantage. Moreover UNIFlow was designed to uniquely address the depth, complexity, and rapid change of molecular science.”
Computer bits are binary, with a value of 0 or 1. By contrast, neurons in the brain can have all kinds of different internal states, depending on the input that they received. This allows the brain to process information in a more energy-efficient manner than a computer. A new study hopes to bring the two closer together.
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.